ELI will welcome, in its offices, national patient associations from the region with a direct interest in lymphoma. They will also be able to benefit from access to an electronic information platform. With patient associations playing a major role in clinical research,

ELI will, in addition, endeavour to involve them in scientific programmes, in information on the advances made in research, in the preparation of protocols and the results of clinical trials.